| INTRODUCTION
Fatal anaphylaxis is very rare. [1] [2] [3] [4] [5] [6] [7] [8] [9] [10] Knowledge of anaphylaxis is gained from administrative databases, mainly official national or regional death records, 1, [4] [5] [6] [8] [9] [10] [11] forensic case series, [7] [8] [9] [10] [11] [12] [13] [14] [15] and national registries of fatal anaphylaxis. 7, 14, 15 Research based on administrative data has revealed the incidence of deaths (0.12 to 1.06 per million person-years) [2] [3] [4] [5] [6] [7] [8] 10 and associated risk factors. 16, 17 Forensic case series have proven superior to clinical-administrative data for characterization of nonspecific but reproducible pathologic findings and for improving our knowledge of the symptoms and causes of fatal anaphylaxis. [7] [8] [9] [10] [11] [12] [13] [14] [15] Forensic case series and administrative data are scarce, probably owing to the low frequency of fatal anaphylaxis. [3] [4] [5] 7, 8, 12, 14, [18] [19] [20] [21] [22] In the few available studies, no association has been established between case source and patient characteristics. 10 We analysed 2 databases of fatal anaphylaxis in Spain from 1998 to 2011: the first includes cases at hospitals in the Spanish hospital system, whereas the second includes forensic cases of fatal anaphylaxis occurring predominantly outside hospitals. Our principal objective was to investigate clinical and demographic characteristics and the causes of fatal anaphylaxis in Spain. We also estimated the incidence of fatal anaphylaxis in Spain using data from the 2 databases and investigated the clinical and demographic differences between both databases.
| MATERIALS AND METHODS

| Collection of patients in the hospital system
The study was carried out using the Spanish Minimum Basic Data Set (MBDS), which is a database created by the Spanish Ministry of Health to collect standardized clinical, demographic, and administrative information on hospital discharges throughout Spain. 23, 24 The system uses the codes of the Spanish version of the International Classification of Diseases, Ninth Revision, Clinical Modification (ICD-9-CM) and covers 98% of public hospitals and many private hospitals in Spain. 25 Possible cases of anaphylaxis were obtained from all discharge diagnoses using 2 strategies whose methodology has been explained elsewhere 23, 26 (Table 1) . A record in the database was considered fatal anaphylaxis if the discharge type was death. We only used the principal diagnoses to select cases of fatal anaphylaxis, because in many records, several possible causes of death can be found within the same record in both the primary and the secondary diagnostic positions. The study period ran from 1998 to 2011.
| Collection of forensic cases
Fatal anaphylaxis is a sudden cause of death and, as such, requires forensic assessment. Such is the case of deaths at home or in public settings or when the patient is taken to hospital but dies before a clinical assessment can be performed.
We selected forensic cases using the database of the Spanish 
| Comparison of the databases
Clinical-demographic characteristics and causes of anaphylaxis from 1998 to 2011 were compared between the Spanish hospital system and the INTCF. A logistic regression model was constructed to predict the characteristics of fatal anaphylaxis in each database.
We determined whether any cases of death by anaphylaxis shared the same date of birth, sex, date of death (with a 2-day overlap), similar comorbidities, and cause of death in both databases.
We attempted to determine the incidence of fatal anaphylaxis in Spain between 1998 and 2011. However, only data from the hospital series were collected comprehensively. Collection of data from the INTCF was not systematic; for instance, data from 3 regions were missing for the 1998-2011 period. Nevertheless, given that the number of cases was significant, we included the cases selected from the INTCF with data from Spanish hospitals for the calculations of incidence. In the case of the 3 missing regions, we assigned a number of deaths that was proportional to the population in these regions during the year 2004 (the middle of the study period), according to the number of deaths in the rest of Spain for which data were available. When this rule was applied, 7 additional cases were added to the number of deaths due to anaphylaxis collected in the INTCF series.
| Statistics
Incidence rates were calculated for the groups (age, sex) using the Spanish population for these groups as the denominator. Standardized data for age and sex were calculated based on data for the Table 2 ).
Finally, 37 cases of fatal anaphylaxis during the period 1998 to 2011 were selected for comparison with the hospital series.
3.2 | Death by anaphylaxis in hospitalized patients:
Incidence and trends
We detected 116 cases of fatal anaphylaxis in the Spanish hospital system during the study period, that is 1.02% of all recorded cases of anaphylaxis (both fatal and nonfatal) (95% CI, 0.8-1.2). Fatal anaphylaxis was more frequent in males than in females, both for the group as a whole (IRR, 1.6; 95% CI, 1.06-2.4; P < 0.001) and for the drug anaphylaxis group (IRR, 2.1; 95% CI, 1.2-3.8; P < 0.001).
Increases in the incidence of fatal anaphylaxis with age were observed for the whole group, both sexes, and drug anaphylaxis, as well as for anaphylaxis of unknown causes (P < 0.001). For the latter, the risk of fatal anaphylaxis increased 1.25-fold to 1.30-fold for each 5-year age group, while the risk of food anaphylaxis remained stable (P = 0.6). (Table S1 , Figure 1 ). We did not observe an increase in death by anaphylaxis during the study period.
| Fatal anaphylaxis: Incidence in Spain and comparison between the databases
Eleven deaths from the INTCF database were in hospital settings, although only 1 was shared by both databases and was excluded.
Consequently, we compared the 2 databases with 115 deaths from the Spanish hospital system and 36 from the INTCF. The incidence rate of fatal anaphylaxis for the whole of Spain using both databases was 0.25 per million person-years (95% CI, 0.24-0.26) during the study period.
The median (IQR) age was lower in cases of deaths analysed in the INTCF database (51.1 [29] years) than in those among hospitalized patients (60.9 [24] years, P = 0.004). In both databases, deaths among males were more frequent than among females, although the percentage of males who died was higher in the INTCF cases (P = 0.01) ( Table 3) . which were over-represented in hospitalized cases (P = 0.002). Obesity and smoking were more frequent in forensic deaths (P = 0.003 and <0.001, respectively) ( Table 5) .
Atopic diseases (asthma, rhinitis, and previous food allergy) or suspected IgE-mediated diseases (previous drug allergy) were found in 24 deaths (20.9%) in the hospital database. A personal history of allergy due to drugs (n = 13) or foods (n = 2) was found in 15
deaths. In the case of foods, 1 patient who died from cow milkmediated anaphylaxis had a previous diagnosis of cow milk allergy, whereas the second case was due to egg but the previous food allergy was coded as being to another food. In the INTCF database, atopic disease and drug allergy accounted for 16 deaths (44.4%)
caused by drug allergy (25%), food allergy (11.1%), and anaphylaxis due to any cause (8.3%). In 3 cases of food allergy, the deaths were due to the culprit food involved in previous episodes, and only drug allergy was more frequent in the INTCF deaths (P = 0.04). Two out of 11 cases of fatal Hymenoptera anaphylaxis had a previous diagnosis of insect venom allergy (Table 5) .
A binomial logistic regression model revealed only fatal anaphylaxis due to an unknown cause to be more frequent in hospitalized patients, whereas having had a previous atopic disease (almost significant) and, above all, death from insect or Hymenoptera venom allergy were more frequent in the forensic cases (Table 6 ).
| Differences between the main causes of death by anaphylaxis
We performed a combined analysis of the 2 databases because of the low number of cases for specific causes of anaphylaxis in some variables and in order to increase the statistical power.
Individuals who died of food anaphylaxis were much younger than those who died of drug anaphylaxis or anaphylaxis of unknown causes (median 23.5 vs ≥48.5 years), although significant differences were not found (P = 0.3) ( Table 7) .
Asthma and rhinitis were more frequent in patients with food anaphylaxis when the remaining causes were taken into consideration (P = 0.002 and P = 0.02). Every main cause of anaphylaxis had higher percentages of a previous personal history of allergy to the same cause, when the remaining causes of fatal anaphylaxis were The total series also includes patients shared by and excluded from both databases.
taken into account, although statistically significant differences were only found for allergy to insect venom (P < 0.001). In the case of drug allergy and allergy to non-ß-lactam antibiotics, the differences were almost significant (P = 0.08 and P = 0.053, respectively). In the same databases, fatal anaphylaxis due to unknown causes accounted for a significant percentage of cases with previous episodes of drug allergy, indicating that a relevant percentage of cases of unknown causes could be due to drug anaphylaxis.
Gender, chronic obstructive pulmonary disease (COPD), and cardiovascular risk were not significantly associated with the main causes of fatal anaphylaxis. However, relevant differences were observed for obesity (P = 0.03, Table 7 ). No cases of ischaemic heart disease were observed in food anaphylaxis; in contrast, several cases were observed for drug, insect, and unknown causes of anaphylaxis, although the differences were not statistically significant.
Higher incidences of death were recorded in the summer months (third trimester) for Hymenoptera anaphylaxis (P = 0.03).
| DISCUSSION
| Fatal anaphylaxis in Spain: Incidence and trends
In our series, the incidence of fatal anaphylaxis was lower than that published in the literature, and the risk of fatal anaphylaxis increased with age. person-years). [1] [2] [3] [4] [5] [6] [7] [8] [9] [10] [11] We analysed a comprehensive series of fatal anaphylaxis in a hospital database and a noncomprehensive series of deaths by anaphylaxis from a forensic database, whereas most previous studies [1] [2] [3] [4] [5] [6] [7] [8] [9] were based on data from national registries of death T A B L E 6 Clinical and demographic characteristics that increase the probability of death due to anaphylaxis in from the Spanish hospital system compared with those of cases from the INTCF database. The total series also includes patients shared by and excluded from both databases certificates. In 3 studies, 1, 5, 27 fatal anaphylaxis in the hospital accounted for 27%-63% of all cases of fatal anaphylaxis recorded in national registries of death certificates; in other words, the estimated incidence of fatal anaphylaxis in Spain could be between 0.29 and 0.62 cases per million person-years (the lower limit is very close to our estimated incidence of fatal anaphylaxis after adding cases from the INTCF). Therefore, our rate underestimated the true incidence of fatal anaphylaxis in Spain.
Consistent with data reported elsewhere, data from the Spanish hospital system revealed no increase in the frequency of fatal anaphy- The frequency of fatal anaphylaxis rises with age, as observed in our series and elsewhere. Elderly people are at greater risk of anaphylaxis because they are more sensitive to complications of anaphylaxis (hypotension, hypoxia, and arrhythmias) owing to the presence of cardiovascular diseases and, consequently, a decreased capacity to overcome the cardiovascular events associated with fatal anaphylaxis. 1, 4 In some studies, the increased risk for men is related to a single specific cause of anaphylaxis, while in other studies, this relationship has not been reported. 2 In the studies of Simon et al 6 and Jerschow et al 8 an increased risk of fatal anaphylaxis was reported for insect venom in men, since outdoor exposure to Hymenoptera is more frequent in men than in women.
| Clinical and demographic characteristics of fatal anaphylaxis
In our study, fatal insect stings were much more frequent in the INTCF database, and unknown causes of death by anaphylaxis were much more frequent in the hospital database. The number of different drugs involved was higher in the hospital than in the INTCF database, T A B L E 7 Previous and current comorbidities and previous allergic diseases in series from the Spanish hospital system (1998) (1999) (2000) (2001) (2002) (2003) (2004) (2005) (2006) (2007) (2008) (2009) (2010) (2011) the foods implicated were seafood in 11 cases, peanuts in 4 cases, and tree nuts in 6 cases. In our hospital series, causes other than tree nuts were more prevalent and included mainly fish, crustaceans, and hen egg, possibly because of local food habits. Different food habits (more consumption of fish or peanuts) in different countries could lead to variations in the prevalence of food allergy.
We found 5 cases of chicken egg anaphylaxis in both databases, in contrast with the low numbers reported in other series. 4 These low numbers could be explained by the fact that cooked egg is less allergic than raw egg, which is rarely ingested in Spain. Another reason could be that, given the small number of deaths due to foodinduced anaphylaxis, some foods appear in some studies and other foods in others.
In their study on drug anaphylaxis, Jerschow et al 8 unlikely that fatal anaphylaxis of unknown cause can be considered idiopathic anaphylaxis owing to the extremely low number of deaths reported in series of idiopathic anaphylaxis. 33 The distribution of comorbidities differed between the 3 principal causes of anaphylaxis in both databases. Atopic comorbidities such as asthma and rhinitis were more prevalent in food anaphylaxis, whereas ischaemic heart disease and obesity or COPD were more frequent in anaphylaxis due to drugs, Hymenoptera venom, and unknown causes. However, the differences were not statistically significant, except for obesity and smoking habit.
In our binomial logistic regression model, fatal anaphylaxis due to an unknown cause was more frequent in hospitalized patients, while
having an atopic disease (almost significant) and death from an insect bite or a Hymenoptera sting (10 times more frequent) were more frequent in the INTCF database. This difference may be explained by the duration of the episodes: some deaths occurred sooner in cases of Hymenoptera anaphylaxis. However, several series, including ours, 13, 19 did not find differences in the rate of immediate and delayed deaths for anaphylaxis due to drugs, foods, or venoms (data not shown). Fatal Hymenoptera anaphylaxis is more probably an untreated event, since it occurs in the field and the time until medical attention can be provided is longer.
Atopic diseases were more frequent in the INTCF group, in which patients were younger and more frequently had food allergy, thus explaining the higher frequency of atopic diseases.
It is possible that the diagnoses were recorded differently in each database, with a higher level of accuracy and comprehensibility for hospital deaths, thus explaining the higher frequency of comorbidity in cases from the hospital system. The higher frequency of comorbidity can also be explained by the fact that people who died in hospital were older.
In summary, more deaths due to anaphylaxis were detected in the Spanish hospital system database. However, deaths due to Hymenoptera were almost exclusively limited to the forensic series.
In our study, the incidence of deaths from anaphylaxis in Spain was among the lowest reported in the literature. Future studies on fatal anaphylaxis should include cases from databases of different origins in order to illustrate the considerable heterogeneity in this type of death.
